Advertisement

CGC

Canopy Growth Corporation

Healthcare · USD

Set alert

Price alert · CGC

All alert types
0.65 USD -0.02 -3.33%
As of Oct 30, 2026 Extended hours 0.66 +1.70%
Bid
0.65 × 5
Ask
0.66 × 1
0.6413 Day range 0.688
0.6525 52-week range 1.92
YTD
-42.76%
1 year
-46.52%
Open
0.688
Prev close
0.675
Mkt cap
293.17M
Vol
2.28M
Avg vol
2.87M
EPS
-0.45
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6413
High
0.688
Forward P/E
-3.73
Beta
1.78
Short ratio
1.44
Inst. own
8.50%
Dividend
0.00
Ex-div date
Earnings
Feb 14, 2025
50-d avg
4.06
200-d avg
6.20
1y target
3.25

5D chart

Chart tools
Interval
CGC five-day price chart0.640.650.670.680.69Oct 26Oct 27Oct 28Oct 30

Key statistics

Market cap
422.81M
Enterprise value
675.75M
Trailing P/E
0.00
Forward P/E
-3.73
PEG ratio
0.00
Price / sales
1.51
Price / book
0.53
EPS (TTM)
-4.97
Beta
1.78
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-201.27%
Revenue (TTM)
280.50M
Revenue growth
-9.50%
Free cash flow
-29.27M
Total cash
235.94M
Total debt
613.52M
Return on equity
-93.03%
Shares outstanding
122.39M
Short % of float
11.79%
50-day average
4.06
200-day average
6.20

Analyst view

Consensus: underperform

Underperform
Price target (mean) 3.25 +397.5% upside
Target (low)
1.94
Target (mean)
3.25
Target (high)
4.31
Ratings (0m) 10 1 buy · 5 hold · 4 sell
  • Strong buy1
  • Buy0
  • Hold5
  • Sell3
  • Strong sell1

Next earnings

Feb 14, 2025

Expected Feb 14, 2025. Consensus EPS estimate -0.23.

Earnings history

Financials — quick view

All financials
CGC Revenue — quarterly 81.17M
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
CGC Net income — quarterly -14.58M
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
CGC EPS — quarterly -0.03
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

CGC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 14, 2025Dec 1, 2024-0.48———
Nov 8, 2024Sep 1, 2024-0.38-0.95-0.57-150.00%
Aug 9, 2024Jun 1, 2024-0.31-0.37-0.06-19.35%
May 30, 2024Mar 1, 2024-0.33-0.28+0.05+15.15%
Feb 9, 2024Dec 1, 2023-0.45-1.79-1.34-297.78%
Nov 9, 2023Sep 1, 2023-1.20-1.80-0.60-50.00%

Upgrades / downgrades

CGC analyst upgrades and downgrades
DateFirmActionFromTo
Jul 9, 2024Piper SandlermainUnderweightUnderweight

About Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada

News

Your note

Sign in to keep a note on CGC — it syncs with the Stock Master app.

Insider holders

CGC insider holders
InsiderRelationLatest transactionDateShares held
Gedeon (Christelle)Senior Officer of IssuerOpening Balance-Initial SEDI ReportJul 31, 20220
Greenstar Canada Investment, L.P.10% Security Holder of IssuerRedemption, retraction, cancelation, repurchaseJun 28, 202266,999,258
Hong (Judy Eun Joo)Senior Officer of IssuerExercise of rightsJun 8, 20222,668
Klein (David Eric)Director or Senior Officer of 10% Security HolderExercise of rightsMay 30, 2022242,006
Lazzarato (David Angelo)Director of IssuerExercise of rightsSep 29, 202215,108
Schmeling (Judy A)Director of IssuerExercise of rightsSep 29, 202241,290

Institution ownership

CGC institution ownership
Holder% heldSharesValueReported
Tidal Investments, LLC1.85%2,012,2145.78MSep 29, 2024
Morgan Stanley0.83%903,8292.59MSep 29, 2024
Millennium Management Llc0.33%360,1771.03MSep 29, 2024
Group One Trading, L.P.0.32%350,0021.00MSep 29, 2024
Geode Capital Management, LLC0.27%289,097829.71KSep 29, 2024
Parallax Volatility Advisers, L.P.0.25%276,870794.62KSep 29, 2024

Fund ownership

CGC fund ownership
Holder% heldSharesValueReported
Amplify ETF Tr-Amplify Alternative Harvest ETF1.84%2,009,9395.77MSep 29, 2024
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF0.08%90,922260.95KOct 30, 2024
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF0.03%32,25392.57KSep 29, 2024
Amplify Seymour Cannabis ETF0.03%35,152100.89KSep 29, 2024
360 Funds-FinTrust Income & Opportunity Fd0.02%26,50076.05KAug 30, 2024
SPDR Portfolio Developed World ex-US ETF0.01%15,15743.50KSep 29, 2024
Advertisement